Whistleblower details GSK plant failures on TV; Five dead in China plant explosion;

> Whistleblower Cheryl Eckard tells 60 Minutes what she saw in 2002 at GlaxoSmithKline's Cidra, Puerto Rico, plant that led the drug giant to a guilty plea and $750 million settlement for distributing adulterated drugs. GSK says it regrets the Cidra manufacturing issues. Article | 13-minute Video | GSK response

> Five workers are reported dead and eight others injured, some with serious burns, in an explosion at the Quanxin Pharmaceutical plant in southwest China. Article

> A financial analyst expects the trend of increasing prices on key biotech drugs that began last year to continue in 2011, despite healthcare reform. Story

> The FDA has become a member of the Pharmaceutical Inspection Convention and the Pharmaceutical Inspection Cooperation Scheme (PIC/S). Item

> The European Medicines Agency anticipates similar workloads for drug applications and practically no increases to its budget for that work program in 2011. Report

> Particle contamination has driven another product recall: six lots of injectable acetylcysteine (Acetadote) manufactured by Cumberland Pharmaceuticals. Cumberland release

> Hong Kong is launching a name-and-shame campaign against retailers caught selling counterfeit medicines. Article

> Elder Pharmaceuticals says it has received approval from the Japan health ministry for its manufacturing facility in the West Indian state of Maharashtra. Report

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.